Webcast: Reducing risk of infection in cord blood transplantation
Recommendations for the prevention and treatment of opportunistic infections
Solutions
You will receive an email with a link to the webinar
Recommendations for the prevention and treatment of opportunistic infections
As an alternative stem cell source, cord blood (CB) has many advantages. However, delayed engraftment, lack of transferred immunity, and a significant incidence of acute graft-versus-host disease renders CB transplant (CBT) recipients at high risk of infectious complications.
Join Dr. Amanda Olson from the University of Texas MD Anderson Cancer Center, as she shares evidence-based recommendations for the prevention and treatment of opportunistic infections in adult patients undergoing CBT. Topics include:
The webinar will review key concepts including the recent important role of letermovir in the prevention of CMV reactivation. In instances where there is a paucity of data, practice recommendations are provided, including the duration of antimicrobial prophylaxis.
Register now to receive a link to the recording and slides.
Recorded Oct 23, 2018
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
Dr. Olson is an Associate Professor of Medicine in the Department of Stem Cell Transplantation and Cellular Therapy where she oversees clinical research related to cord blood transplantation, mesenchymal stem cell manipulation and cellular therapy. Dr. Olson is the Principal Investigator for several cellular therapy trials. She completed a Hematology and Oncology fellowship at Memorial Sloan-Kettering in 2013 where her research focus on optimization of umbilical cord blood transplantation and infectious complications following hematopoietic stem cell transplant in adults.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.